In contrast, prolongation of prothrombin time (PT) and activated partial thromboplastin time (aPTT) in patients with COVID-19 is only moderate, and the findings of an increase in both fibrinogen and factor VIII can be interpreted as a more typical finding of response to acute infection of COVID-19 than that of DIC [17]. The gene discussed is F2; the disease is COVID-19.